Frontlight ResearchEarly access
Duchenne muscular dystrophy trials in Georgia
1 trial · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in GeorgiaSafety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy
- Where
- Tbilisi
- Age
- 9 years and over
- People
- 36 worldwide
- Run by
- Keros Therapeutics, Inc.
See details and how to joinNCT07704099